Clinical characteristics of testicular non-seminomatous germ cell tumor from West China: a 10-year experience

作     者：Zeyu Chen Xingyuan Wang Dehong Cao Shi Qiu Jin Li Bo Chen Yin Huang Yige Bao Liangren Liu Qiang Wei Zeyu Chen;Xingyuan Wang;Dehong Cao;Shi Qiu;Jin Li;Bo Chen;Yin Huang;Yige Bao;Liangren Liu;Qiang Wei

作者机构：Department of UrologyInstitute of UrologyWest China HospitalSichuan UniversityChengduSichuan 610041China West China School of MedicineSichuan UniversityChengduSichuan 610041China Center of Biomedical Big DataWest China HospitalSichuan UniversityChengduSichuan 610041China. 

出 版 物：《Chinese Medical Journal》 (中华医学杂志（英文版）)

年 卷 期：2022年第135卷第13期

页      面：1631-1633页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

基　　金：funded by the National Natural Science Foundation of China(Nos.81370855,81770857,and 81200551) the Project of Sichuan Province Science and Technology Department(Nos.2015SZ0230 and 2017KJT0034) 

主　　题：neoplasms chemotherapy patients 

摘      要：To the Editor:Testicular tumor represents 1%of male neoplasms and 5%of urogenital ***-seminomatous germ cell tumor(NSGCT)accounts for nearly 40%of all testicular *** survival of patients with NSGCT has been improved because of advanced multimodal therapies(orchiectomy,and if necessary,subsequent chemotherapy).[1]However,to the best of our knowledge,survival of NSGCT patients has not been studied in a large Chinese cohort ***,this study assessed the clinical characteristics,treatments,and outcomes of patients with NSGCT.